Bio-Techne Corporation (TECH)
NASDAQ: TECH · IEX Real-Time Price · USD
62.21
-0.52 (-0.83%)
Apr 18, 2024, 4:00 PM EDT - Market closed
Bio-Techne Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 180.57 | 172.57 | 199.09 | 146.63 | 100.89 | 121.99 | 91.61 | 64.24 | 54.53 | 318.57 | Upgrade
|
Short-Term Investments | 23.74 | 74.46 | 32.46 | 124.27 | 65.15 | 59.76 | 66.1 | 31.6 | 56.39 | 44.79 | Upgrade
|
Cash & Cash Equivalents | 204.31 | 247.03 | 231.55 | 270.89 | 166.03 | 181.75 | 157.71 | 95.84 | 110.92 | 363.35 | Upgrade
|
Cash Growth | -17.29% | 6.68% | -14.52% | 63.16% | -8.65% | 15.24% | 64.57% | -13.60% | -69.47% | 9.14% | Upgrade
|
Receivables | 218.47 | 194.55 | 145.39 | 122.53 | 137.47 | 120.3 | 116.83 | 93.39 | 70.03 | 55 | Upgrade
|
Inventory | 171.64 | 141.12 | 116.75 | 103.15 | 91.05 | 85.65 | 60.15 | 57.1 | 49.58 | 38.85 | Upgrade
|
Other Current Assets | 27.07 | 22.86 | 16.92 | 24.34 | 18.06 | 10.67 | 13.33 | 7.56 | 17.75 | 12.21 | Upgrade
|
Total Current Assets | 621.48 | 605.56 | 510.61 | 520.92 | 412.61 | 398.37 | 348.03 | 253.89 | 248.28 | 469.41 | Upgrade
|
Property, Plant & Equipment | 324.53 | 288.8 | 281.74 | 248.29 | 154.04 | 145.35 | 135.12 | 132.36 | 129.75 | 117.12 | Upgrade
|
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.02 | Upgrade
|
Goodwill and Intangibles | 1,407 | 1,354 | 1,459 | 1,245 | 1,312 | 1,044 | 1,031 | 741.41 | 683.48 | 260.25 | Upgrade
|
Other Long-Term Assets | 285.3 | 46.83 | 11.58 | 13.52 | 5.67 | 5.27 | 44 | 1.92 | 1.85 | 1.69 | Upgrade
|
Total Long-Term Assets | 2,017 | 1,689 | 1,752 | 1,507 | 1,472 | 1,195 | 1,210 | 875.69 | 815.08 | 393.08 | Upgrade
|
Total Assets | 2,639 | 2,295 | 2,263 | 2,028 | 1,884 | 1,593 | 1,558 | 1,130 | 1,063 | 862.49 | Upgrade
|
Accounts Payable | 29.18 | 33.87 | 33.38 | 29.03 | 19.61 | 18.45 | 85.26 | 59.15 | 52.47 | 9.65 | Upgrade
|
Deferred Revenue | 23.07 | 23.41 | 19 | 13.05 | 9.08 | 8.11 | 5.97 | 4.72 | 3.38 | 0 | Upgrade
|
Current Debt | 11.2 | 24.43 | 24.1 | 22.04 | 12.5 | 0 | 0 | 3.76 | 4.02 | 5.95 | Upgrade
|
Other Current Liabilities | 65.06 | 94.32 | 75.8 | 42.56 | 60.79 | 52.95 | 44.3 | -13.48 | -20.1 | 10.79 | Upgrade
|
Total Current Liabilities | 128.51 | 176.02 | 152.28 | 106.67 | 101.99 | 79.51 | 135.52 | 54.15 | 39.77 | 26.39 | Upgrade
|
Long-Term Debt | 443.77 | 301.54 | 396.45 | 411.49 | 492.66 | 339 | 343.77 | 91.5 | 73 | 7 | Upgrade
|
Other Long-Term Liabilities | 99.9 | 116.23 | 142.99 | 128.24 | 124.18 | 95.63 | 129.3 | 104.65 | 103.66 | 33.84 | Upgrade
|
Total Long-Term Liabilities | 543.67 | 417.78 | 539.44 | 539.73 | 616.84 | 434.63 | 473.07 | 196.15 | 176.66 | 40.84 | Upgrade
|
Total Liabilities | 672.18 | 593.79 | 691.72 | 646.4 | 718.82 | 514.14 | 608.59 | 250.3 | 216.43 | 67.23 | Upgrade
|
Total Debt | 454.97 | 325.97 | 420.55 | 433.53 | 505.16 | 339 | 343.77 | 95.26 | 77.02 | 12.95 | Upgrade
|
Debt Growth | 39.57% | -22.49% | -2.99% | -14.18% | 49.01% | -1.39% | 260.88% | 23.67% | 494.96% | - | Upgrade
|
Retained Earnings | 1,309 | 1,123 | 1,085 | 1,057 | 931.93 | 876.93 | 799.03 | 770.55 | 713.85 | 653.28 | Upgrade
|
Comprehensive Income | -66.06 | -75.2 | -57.29 | -97.2 | -83.52 | -44.81 | -48.94 | -70.41 | -30.59 | -5.39 | Upgrade
|
Shareholders' Equity | 1,967 | 1,702 | 1,563 | 1,381 | 1,166 | 1,079 | 949.63 | 879.28 | 846.94 | 795.27 | Upgrade
|
Net Cash / Debt | -250.66 | -78.94 | -189 | -162.63 | -339.13 | -157.25 | -186.06 | 0.58 | 33.9 | 350.41 | Upgrade
|
Net Cash / Debt Growth | - | - | - | - | - | - | - | -98.30% | -90.33% | 5.25% | Upgrade
|
Net Cash Per Share | -1.55 | -0.48 | -1.17 | -1.03 | -2.18 | -1.03 | -1.24 | 0.00 | 0.23 | 2.37 | Upgrade
|
Working Capital | 492.97 | 429.54 | 358.32 | 414.25 | 310.62 | 318.86 | 212.5 | 199.74 | 208.52 | 443.02 | Upgrade
|
Book Value Per Share | 12.51 | 10.85 | 10.09 | 9.04 | 7.71 | 7.20 | 6.36 | 5.91 | 5.71 | 5.39 | Upgrade
|